The action of neuroleptics in rats with altered catecholamine metabolism. 3. The effect of chlorpromazine, haloperidol and thioridazine on the brain dopamine and serotonin contents in the rats pretreated with MAO inhibitors.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D002540:Cerebral Cortex / Q000032:analysis; D002746:Chlorpromazine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000032:analysis; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D004347:Drug Interactions; D005260:Female; D006220:Haloperidol / Q000494:pharmacology*; D006624:Hippocampus / Q000032:analysis; D007031:Hypothalamus / Q000032:analysis; D008297:Male; D008526:Medulla Oblongata / Q000032:analysis; D008636:Mesencephalon / Q000032:analysis; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D011149:Pons / Q000032:analysis; D051381:Rats; D012701:Serotonin / Q000032:analysis / Q000378:metabolism*; D013788:Thalamus / Q000032:analysis; D013881:Thioridazine / Q000494:pharmacology*
D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D010293:Pargyline; D006220:Haloperidol; D013881:Thioridazine; D009526:Nialamide; D002746:Chlorpromazine; D004298:Dopamine